Brief: PCI Biotech Holding Q3 operating loss flat at NOK 9.5 mln
Nov 22 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q3 operating loss 9.5 million Norwegian crowns ($1.1
million) versus loss 9.4 million crowns year ago
* Proposes to carry out fully underwritten rights issue of
70 million crowns at subscription price of 7 crowns per share
* Q3 other income 2.3 million crowns versus loss 2.4 million
crowsn year ago
Source text for Eikon: ID:nGNE2ZB9MS
Further company coverage: PCIB.OL
($1 = 8.5391 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process